0001209191-11-058411.txt : 20111129
0001209191-11-058411.hdr.sgml : 20111129
20111129211334
ACCESSION NUMBER: 0001209191-11-058411
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111128
FILED AS OF DATE: 20111129
DATE AS OF CHANGE: 20111129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MANHARD KIMBERLY
CENTRAL INDEX KEY: 0001202094
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33734
FILM NUMBER: 111232539
MAIL ADDRESS:
STREET 1: C/O ARDEA BIOSCIENCES, INC.
STREET 2: 4939 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE
CENTRAL INDEX KEY: 0001103390
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943200380
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4939 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-652-6500
MAIL ADDRESS:
STREET 1: 4939 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE
DATE OF NAME CHANGE: 20000127
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2011-11-28
0
0001103390
Ardea Biosciences, Inc./DE
RDEA
0001202094
MANHARD KIMBERLY
4939 DIRECTORS PLACE
SAN DIEGO
CA
92121
0
1
0
0
SVP, Regulatory & Dev Ops
Common Stock
2011-11-28
4
M
0
5000
3.90
A
14731
D
Common Stock
2011-11-28
4
S
0
5000
17.6714
D
9731
D
Employee Stock Option (Right to Buy)
3.90
2011-11-28
4
M
0
5000
0.00
D
2016-12-20
Common Stock
5000
35000
D
The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 22, 2011.
Includes 344 shares acquired under the Ardea Biosciences, Inc. 2000 Employee Stock Purchase Plan on November 14, 2011.
The range of sales prices received was $17.06 to $17.92. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
25% of the shares subject to the stock option vested and became exercisable on December 21, 2007. The remaining shares vest in equal monthly installments over the following 3 years.
/s/ Kimberly J. Manhard
2011-11-29